Assessing placebo effects without placebo groups: an untapped possibility?
- PMID: 11207391
- DOI: 10.1016/S0304-3959(01)00265-2
Assessing placebo effects without placebo groups: an untapped possibility?
Comment in
-
Controlled clinical drug trials: creating a new paradigm.Pain. 2002 Jan;95(1-2):194. doi: 10.1016/s0304-3959(01)00384-0. Pain. 2002. PMID: 11790484 No abstract available.
Comment on
-
Response variability to analgesics: a role for non-specific activation of endogenous opioids.Pain. 2001 Feb 15;90(3):205-215. doi: 10.1016/S0304-3959(00)00486-3. Pain. 2001. PMID: 11207392 Clinical Trial.
References
-
- Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19:484-494.
-
- Beecher HK. The powerful placebo. J Am Med Assoc. 1955;159:1602-1606.
-
- Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci. 1999;19(9):3639-3648.
-
- Gracely RH, Dubner R, Wolskee PJ, Deeter WR. Placebo and naloxone can alter postsurgical pain by separate mechanisms. Nature. 1983;306:264-265.
-
- Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain. 1983;16:129-143.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
